M&A Talks Europe

5. Sanofi spin-off: bidding war over the future of Pharma

30 min · 14 de oct de 2024
Portada del episodio 5. Sanofi spin-off: bidding war over the future of Pharma

Descripción

In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de M&A Talks Europe!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

5 episodios